International BioChemical Industries Inc has recently received from the Mexican Patent Office an approval extending IBCI's antimicrobial, securing the rights to a broader protection of its proprietary technology. This new patent approval helps to solidify IBCI's positioning in the Mexican markets, bringing achievement to the ongoing plans for international growth.

Deirdre Baker, IBCI's General Manager, stated, "This new Patent approval contributes a great deal to our competitive advantage, creates new barriers to entry for our competition to participate in the antimicrobial and antibacterial industries, and further enhances and protects IBCI's intellectual property portfolio."

International BioChemical Industries emerging growth company focused in biotechnology and antimicrobial products. Its core business is committed to the discovery, development, marketing and sale of surface-modifying antimicrobial and biostatic products. The company's antimicrobial technology is a revolutionary alternative to conventional sanitizers, disinfectants, bleaches, biocides or preservatives primarily because it kills bacteria, including HIV, on contact and can remain active for extended time periods.